The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
Elshoma McCoy, 49, of 176 Waverly St., Framingham, is charged with illegal possession of a firearm; illegal possession of a ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
Sisitsky submitted his plan to comply with the law late last month after city councilors voted to table discussing the issue ...
Although the product had previously been approved in Europe, GTC Biotherapeutics of Framingham, Massachusetts ... follows closely on the heels of the FDA final guidance issued a month earlier ...